Background/Aims: Adenosine 5'-monophosphate (AMP)-activated protein kinase (Ampk) modulates a wide array of cellular functions and regulates various ion channels and transporters. In failing human hearts an increased Ampkα1 activity was observed. The present study aimed to uncover the impact of Ampkα1 on cardiac electrical remodeling. Methods: Gene-targeted mice lacking functional Ampkα1 (Ampkα1 -/-) and corresponding wild-type mice were exposed to pressure overload by "transverse aortic constriction" (TAC). In vivo electrophysiology was performed with a single catheter technique, myocardial conduction velocities and conduction characteristics investigated in isolated hearts, transcript levels quantified by RT-PCR and protein abundance determined by Western blotting. Moreover, connexin 43 (Cx43) was expressed in Xenopus oocytes with or without coexpression of wild-type or mutant AMPK and Cx43 protein abundance quantified utilizing confocal microscopy. Results: TAC treatment increased Ampkα1 protein expression in cardiac tissue from wild-type mice. TAC further increased left ventricular conduction inhomogeneity and triggered conduction blocks, effects blunted in the Ampkα1 -/-mice. TAC treatment decreased Cx43 protein abundance in cardiac tissue, an effect significantly blunted in the Ampkα1 -/-mice. TAC treatment did not modify Cx43 mRNA levels but increased ubiquitination of Cx43 protein, an effect mitigated by Ampkα1 deficiency. As shown in Xenopus oocytes, Cx43 cell membrane protein abundance I. Alesutan and J. Voelkl contributed equally and thus share first authorship.
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Introduction
Electrical coupling by gap junctions is essential for action potential propagation throughout cardiac muscle [1] . Connexin 43 (Cx43) is the major gap junction protein in ventricular myocytes [1] . Cx43-dependent gap junction coupling underlies dynamic alterations [2] . In failing hearts, "electrical remodeling" modifies activity of ion channels, excitation-contraction coupling and intercellular gap junctions [3] . Electrical remodeling is a hallmark of cardiac failure [3] which is associated with high morbidity and mortality at least partially due to fatal arrhythmias [4] . Cardiac electrical remodeling involves altered function of the gap junction protein Cx43 [1] .
A crucial regulator involved in the myocardial stress response is adenosine 5'-monophosphate (AMP)-activated protein kinase (Ampk) [5] . Ampk is activated by increase of cytosolic Ca 2+ concentration as well as AMP/ATP concentration ratio and thus senses cellular Ca 2+ overload and energy depletion [6] . Ampk is a heterotrimer consisting of a catalytic alpha (α) subunit and regulatory beta (β) and gamma (γ) subunits [5] . Two isoforms of the catalytic α subunit exist with distinct subcellular localization: Ampkα1 (encoded by the Prkaa1 gene) found in the non-nuclear fraction and Ampkα2 (encoded by the Prkaa2 gene) localized in both nucleus and non-nuclear fraction [7] .
In cardiac tissue, Ampkα2 is the dominant isoform and plays an important role in cardiac ischemia, hypertrophy and failure [5] . Ampk activity is increased in left ventricular (LV) hypertrophy, which reduces expression of the Ampkα2 isoform but increases the expression of the Ampkα1 isoform [8] . The contribution of Ampkα1 to Ampk activity is more pronounced in human than in mouse hearts [9] . In the failing human heart, the activity of the catalytic Ampkα isoforms is shifted towards Ampkα1 [9] .
Ampk is a powerful regulator of channels, carriers and Na + /K + ATPase [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . The kinase is involved in the regulation of cardiac sodium and potassium channels [11, 17] . Ampkα1 further downregulates gap junction protein beta 2 [12] . Mutations in the Ampkγ2 subunit leading to increased Ampk activity are associated with cardiac electrophysiologic abnormalities, hypertrophy and glycogen storage disease [20] .
The present study investigated the role of Ampkα1 on cardiac electrophysiology and gap junction remodeling during pressure overload. To this end, cardiac electrical remodeling and Cx43 expression were measured in gene-targeted mice lacking functional Ampkα1 (Ampkα1 -/-) and corresponding wild-type mice exposed to pressure overload by "transverse aortic constriction" (TAC).
Materials and Methods
Murine aortic banding
All animal experiments were conducted according to the German law for the welfare of animals and were approved by local authorities. Ampkα1 knockout mice were described previously [21, 22] . Male mice of 9-12 weeks of age were used for the experiments. Cardiac pressure overload was induced by transverse aortic constriction (TAC) [23] . Briefly, mice were anaesthetized and placed on a heating pad. After orotracheal intubation and ventilation (Harvard minivent, Harvard Apparatus, Holliston, USA), the intercostal space was opened by a small incision in the muscular thoracic wall. The transverse aorta was exposed and constricted between the brachiocephalic artery and the left carotid artery by the width of a 27-G canula using a 7-0 filament. Sham treatment was performed similarly but without constriction of the filament. Animals were treated with buprenorphine (0.05mg/kg BW) after the procedure.
Electrophysiological investigation
The in vivo electrophysiological investigations (EPI) were carried out with a single catheter technique [24] . Under inhalative anaesthesia (isoflurane; induction period 2.5 vol.%, maintenance 1.2 vol.% in 70% N 2 O/ 30% O 2 ) the jugular vein was dissected and a 2-French octapolar mouse electrophysiological catheter (Ciber Mouse, NuMed Inc., NY, USA) was positioned into the right cardiac cavities on atrial and ventricular level.
Functional electrophysiological parameters were examined using a universal isolated stimulator (Hugo Sachs Elektronik, Type 263, Germany) and custom written software (Stimulus V3.2, H. Begerau, Bonn, Germany). Refractory periods were determined according to established procedure protocols [25] . The susceptibility to ventricular tachyarrhythmias (VTs) was determined by ventricular extrastimulus pacing (S1S1: 120 ms, 100 ms, and 80 ms followed by up to 3 extra beats) and ventricular burst stimulation (1s at S1S1: 50-10 ms, 10 ms stepwise reduction; stimulus voltages 1.5 and 3.0 V). VTs were defined as ≥4 consecutive ventricular ectopic beats.
Langendorff-perfusion and epicardial mapping
Myocardial conduction velocities and conduction characteristics were investigated after excorporation of the hearts and Langendorff-perfusion with Krebs-Henseleit buffer at constant pressure (80 mmHg; Langendorff apparatus by Radnoti Technologies, Monrovia, CA, USA; perfusate composition: NaCl 110 mM, KCl 4.6 mM, MgSO 4 1.2 mM, CaCl 2 2 mM, NaH 2 PO 4 2 mM, NaHCO 3 25 mM, glucose 8.3 mM, Na-pyruvate 2 mM, gassed with carbogen (O 2 95%, CO 2 5%), pH 7.35-7.45, temperature 37°C) as previously described [26] . Using a 72-electrode array (FlexMEA72, Multi Channel Systems, Reutlingen, Germany, interelectrode distance: longitudinal 750 µm, transversal 625 µm) 76 activation maps in spontaneous sinus rhythm were analyzed from left ventricular epicardium (Cardio 2D Software, V2.0.3, Multi Channel Systems, Reutlingen, Germany). Considering the direction of the electrode array in relationship to the myocardial fiber orientation, longitudinal and transversal conduction velocities could be calculated. The inhomogeneity index as an index of local conduction slowing for each electrode [27] was calculated using custom-programmed software (Latency version 3.0; H. Begerau, Bonn, Germany). Significant conduction blocks were defined as conduction delay of >4 ms between adjacent electrodes.
Quantitative RT-PCR
Total RNA was isolated from snap frozen murine heart samples using Trifast Reagent (Peqlab, Erlangen, Germany) according to the manufacturer's instructions. Reverse transcription of 2 µg RNA was performed using oligo(dT) [12] [13] [14] [15] [16] [17] [18] primers (Invitrogen, Karlsruhe, Germany) and SuperScript III Reverse Transcriptase (Invitrogen, Karlsruhe, Germany). cDNA samples were treated with RNase H (Invitrogen, Karlsruhe, Germany). Quantitative real-time PCR was performed with the iCycler iQ TM Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA) and iQ Sybr Green Supermix (Bio-Rad Laboratories, Hercules, CA) according to the manufacturer's instructions. The following primers were used (5'→3' orientation):
Cx43 fw: ACAAGGTCCAAGCCTACTCCA; Cx43 rev: CCGGGTTGTTGAGTGTTACAG; Gapdh fw: AGGTCGGTGTGAACGGATTTG; Gapdh rev: TGTAGACCATGTAGTTGAGGTCA; Prkaa1 fw: GACCGGACATAAAGTGGCTGT; Prkaa1 rev: CCACGTCAAGGCTCCGAAT; Prkaa2 fw: ATGGTTGTCCATAGGGACCTG; Prkaa2 rev: GCGATCCACAGCTAGTTCGTAG.
The specificity of the PCR products was confirmed by analysis of the melting curves and in addition by agarose gel electrophoresis. All PCRs were performed in duplicate and relative mRNA fold changes were calculated by the 2 -ΔΔCt method using Gapdh as internal reference.
Immunostaining and confocal microscopy For immunohistochemistry [28] , cardiac tissues were immediately frozen in mounting medium (Tissue-Tek, Sakura Finetek) and sectioned at a thickness of 8 μm on coated slides. Heart sections were dried for 30 min at RT and fixed in methanol for 10 min at RT. To reduce nonspecific background staining, slides were incubated with 5% normal goat serum in PBS/ 0.1% Triton X-100 for 1 hour at RT. Sections were incubated overnight at 4°C with rabbit polyclonal anti-Cx43 antibody (diluted 1:50, Cell Signaling). Binding of primary antibody was visualized using goat anti-rabbit Alexa Fluor488-conjugated antibody (diluted 1:1,000, Invitrogen) incubated for 1 hour at RT. Nuclei were stained using DRAQ-5 dye (diluted 1:1,000, Biostatus) and actin using Rhodamine Phalloidin (diluted 1:100, Invitrogen). The slides were mounted with Prolong Gold antifade reagent (Invitrogen). Images were collected with a confocal laser-scanning microscope (LSM 510, Carl Zeiss MicroImaging GmbH) using a water immersion A-Plan ×40/1.2W DICIII. Confocal images are representative for 4 mice/ group. Negative controls were carried out simultaneously with all experiments by omitting incubation with primary antibody.
Analysis of Cx43 ubiquitination
Murine heart tissues were lysed with ice-cold IP lysis buffer (Thermo Fisher Scientific, Rockford, IL, USA) supplemented with complete protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific, Rockford, IL, USA). After centrifugation at 10000 rpm for 5 min, protein concentration was determined by Bradford assay (Biorad Laboratories, Hercules, CA). Immunoprecipitation of Cx43 from heart tissue samples was performed by using Pierce Direct IP kit (Thermo Fisher Scientific, Rockford, IL, USA) according to the manufacturer's instructions. To pre-clear the lysate, fixed amounts of protein (600 µg) were incubated with control agarose resine (Thermo Fisher Scientific, Rockford, IL, USA) for 1 hour at 4 °C on a rotator. Coupling of 4 µl rabbit polyclonal anti-Cx43 antibody (Cell Signaling) to the AminoLink Plus coupling resin (Thermo Fisher Scientific, Rockford, IL, USA) was performed for 2 hours at RT. The pre-cleared lysate was incubated with the immobilized antibody to form the immune complex overnight at 4 °C on a rotator. Then, immune complexes were washed to remove non-bound proteins and low pH elution buffer was used to dissociate the bound antigen from the antibody. The eluted proteins were boiled in Roti-Load1 Buffer (Carl Roth GmbH, Karlsruhe, Germany) by heating for 5 min at 95°C. Proteins were separated on 10% SDS-polyacrylamide gels and transferred to PVDF membranes. The membranes were incubated overnight at 4°C with rabbit antiubiquitin antibody (diluted 1:1000, Cell Signaling, Danvers, MA, USA) and then with goat anti-rabbit HRPconjugated antibody (diluted 1:1000, Cell Signaling) for 1 hour at RT. To remove antibodies, membranes were incubated in stripping buffer (Thermo Fisher Scientific, Rockford, IL, USA) for 10 min at RT and reprobed with rabbit polyclonal anti-Cx43 antibody (diluted 1:1000, Cell Signaling). Antibody binding was detected with the ECL detection reagent (Thermo Fisher Scientific, Rockford, IL, USA) and bands were quantified using Quantity One Software (Bio-Rad, München, Germany). Results are shown as the ratio of ubiquitin to Cx43 protein normalized to the sham treated wild-type mice.
Western blot analysis
Murine heart tissues were lysed with ice-cold IP lysis buffer (Thermo Fisher Scientific) supplemented with complete protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific). After centrifugation at 10000 rpm for 5 min, protein concentration was estimated by Bradford assay (Biorad Laboratories, Hercules, CA) and proteins were boiled in Roti-Load1 Buffer (Carl Roth GmbH) at 100°C for 10 min. Proteins were separated on SDS-polyacrylamide gels and transferred to PVDF membranes. The membranes were incubated overnight at 4°C with the following primary antibodies: rabbit monoclonal anti-Ampkα1 antibody (diluted 1:1000, Novus Biologicals), rabbit monoclonal anti-phospho-Ampkα (Thr 172 ) antibody, rabbit monoclonal anti-Ampkα antibody, rabbit polyclonal anti-phospho-ACC (Ser 79 ) antibody, rabbit polyclonal anti-ACC antibody, rabbit polyclonal anti-Cx43 antibody and rabbit anti-GAPDH antibody (diluted 1:1000, Cell Signaling) and then with secondary goat anti-rabbit HRP-conjugated antibody (diluted 1:1000, Cell Signaling) for 1 hour at RT. For loading controls, the membranes were stripped with stripping buffer (Thermo Fisher Scientific, Rockford, IL, USA) for 10 min at RT. Antibody binding was detected with the ECL detection reagent (Thermo Fisher Scientific). Bands were quantified with Quantity One Software (Bio-Rad Laboratories) and results are shown as the ratio of phosphorylated to total protein to Gapdh and as the ratio of total protein to Gapdh normalized to the sham treated wild-type mice.
Constructs
For generation of cRNA, constructs were used encoding AMPKα1-HA, AMPKβ1-Flag, AMPKγ1-HA [29] , constitutively active mutant R70Q AMPKγ1-HA [30] and kinase-dead mutant K45R AMPKα1-HA [31] in POL1, Xenopus oocyte expression vector and mouse tagged Cx43-eGFP inserted in the plasmid pSGEM, Xenopus oocyte expression vector. The construct for mouse Cx43-eGFP was obtained by subcloning the insert into Alesutan et 
pSGEM vector from pMJ-Cx43-eGFP (kind gift from Prof. Dr. Klaus Willecke) using EcoRI -NotI restriction sites. The eGFP-tagged Cx43 construct was sequenced to confirm the insert and tag in frame. cRNA was synthesized as described previously [32, 33] .
Confocal microscopy in Xenopus oocytes
Xenopus oocytes were prepared as previously described [34, 35] . cRNA (4.6 ng) encoding either AMPKα1-HA + AMPKβ1-Flag + AMPKγ1-HA (AMPK ) were injected on the first day and 23 ng of cRNA encoding Cx43-eGFP on the third day after preparation of the Xenopus oocytes [19, 36] . All experiments were performed 3 days after the first injection. Oocytes were maintained at 17°C in ND96-A solution containing 88.5 mM NaCl, 2 mM KCl, 1.8 mM CaC1 2 , 1 mM MgC1 2 , 5 mM HEPES, 0.11 mM tretracycline, 4 μM ciprofloxacin, 0.22 mM gentamycin (Refobacin), 0.5 mM of the oocyte maturation inhibitor theophylline (Euphylong) [37] , and 5 mM sodium pyruvate. The pH was adjusted to 7.4.
To visualize Cx43-eGFP cell surface expression, Xenopus oocytes were fixed in 4% paraformaldehyde/ PBS for 2 hours at RT. After washing with PBS, Xenopus oocytes were analyzed by a fluorescence laser scanning microscope (LSM510, CarlZeiss MicroImaging GmbH, Germany) with A-Plan 10x/0.25, focused on the midline of the oocytes. Brightness and contrast settings were kept constant during imaging of all oocytes in each injection series. Confocal images are representative for three independent experiments. The fluorescence intensity reflecting Cx43-eGFP membrane abundance was quantified by ZEN2009 software (Zeiss, Göttingen, Germany) [38] .
Statistics
Data are shown as arithmetic means ± SEM unless indicated otherwise. Normality was tested with Shapiro-Wilk test. Non-normal data were transformed (log or reciprocal) prior to statistical testing to provide normality according to Shapiro-Wilk test. Statistical testing was performed by one-way Anova followed by Tukey-test for homoscedastic data or Games-Howell test for heteroscedastic data. Non-normal data was tested by the Steel-Dwass method. Two groups were compared by unpaired two-tailed t-test. Left ventricular conduction blocks are shown as individual measurements and box-plots (generalized linear model, exponential distribution). The probability of VT is shown descriptive. A p<0.05 was considered statistically significant.
Results
A first series of experiments explored whether cardiac Ampkα1 expression is modified following pressure overload induced by transverse aortic constriction (TAC). As a result, in wild-type mice (Ampkα1
), 2 weeks of TAC treatment significantly increased cardiac Ampkα1 protein abundance compared to sham treated mice (Fig. 1A) . TAC treatment did not significantly modify Prkaa1 and Prkaa2 mRNA levels (Fig.1B) . The Ampkα protein abundance was increased following TAC treatment without modifying ACC (Acetyl-CoA carboxylase) phosphorylation, a target phosphorylated by Ampk [39] (Fig. 1C) .
To investigate whether Ampkα1 is involved in electrical remodeling of the heart, electrophysiological investigations and cardiac mapping were performed on hearts from Ampkα1 +/+ mice and Ampkα1 knockout mice (Ampkα1 -/-) following TAC or sham procedure (Fig. 2) . TAC treatment led to an increase of the LV inhomogeneity index in Ampkα1 +/+ hearts as compared to sham treated hearts, effects significantly blunted in the Ampkα1 -/-hearts (Fig.  2B) . Furthermore, following TAC treatment, Ampkα1 +/+ hearts displayed more conduction blocks >4ms than Ampkα1 -/-hearts (Fig. 2C) . Surprisingly, both longitudinal and transversal conduction velocity tended to be lower in Ampkα1
-/-hearts as compared to Ampkα1 +/+ hearts, irrespective of TAC treatment (Fig. 3 A,B) . The conduction velocity was not further reduced by TAC treatment in Ampkα1 -/-hearts. Longitudinal conduction velocity was significantly reduced (Fig. 3A) and ventricular refractory period was significantly increased (Fig. 3C) following TAC treatment in Ampkα1 +/+ hearts, but not in Ampkα1 -/-hearts. The probability to induce ventricular tachycardias following TAC treatment was low irrespective of the genotype (Fig. 3D) . Taken together, Ampkα1 is involved in cardiac electrical remodeling following pressure overload. In search for a structural substrate accounting for the increased conduction inhomogeneity in TAC treated Ampkα1 +/+ mice, protein abundance and localization of the gap junction protein connexin 43 (Cx43) were investigated. As shown by confocal imaging and Western blotting, TAC treatment decreased the expression and deranged the organization of Cx43 protein in cardiac tissue from Ampkα1 +/+ mice, effects mitigated in the Ampkα1 -/-mice (Fig. 4A,B) . Furthermore, TAC treatment increased ubiquitination of Cx43 protein in Ampkα1 +/+ mice, an effect again significantly blunted in Ampkα1 -/-mice (Fig. 4C ). Cx43 mRNA levels were not significantly modified by TAC treatment and were not different between Ampkα1
-/-and Ampkα1 +/+ mice (Fig.4D) . Thus, Ampkα1 down-regulates Cx43 protein abundance in cardiac tissue by increasing the ubiquitination-mediated degradation.
To further elucidate the Ampkα1-sensitive regulation of the gap junction protein Cx43, Xenopus oocytes were injected with cRNA encoding Cx43-eGFP alone or together with wild-type AMPK WT (AMPKα1 + AMPKβ1 + AMPKγ1), with catalytically inactive mutant AMPK αK45R ( K45R AMPKα1 + AMPKβ1 +AMPKγ1) or with constitutively active mutant AMPK γR70Q (AMPKα1-HA + AMPKβ1 +
R70Q
AMPKγ1) and Cx43 protein abundance in the cell membrane was determined by confocal microscopy in Cx43-eGFP-expressing Xenopus oocytes. As shown in Fig. 5A ,B, the expression of Cx43-eGFP protein in the Xenopus oocytes cell membrane was significantly decreased following coexpression of wild-type AMPK WT and of constitutively active AMPK
γR70Q
. In contrast, coexpression of the catalytically inactive AMPK αK45R did not significantly modify Cx43-eGFP protein cell surface expression. Thus, kinase activity is required for the effect of AMPK on Cx43 protein cell membrane abundance. transcript levels. Thus, Ampkα1 downregulates Cx43 protein abundance in cardiac tissue presumably by accelerating Cx43 protein degradation. The Cx43 protein is regulated by ubiquitination [41] [42] [43] . Ampk has previously been shown to regulate ubiquitin ligases, and thus protein degradation through the "ubiquitin proteasome system" [44] [45] [46] [47] . Our findings suggest that Ampkα1 regulates the ubiquitination with subsequent internalization and degradation of the Cx43 protein. Along those lines the decline of Cx43 abundance in cardiac hypertrophy involves posttranscriptional mechanisms [48] . The reduction of Cx43 protein in the cell membrane presumably contributes to the observed increased LV inhomogeneity index in wild-type mice following TAC treatment. Despite the changes in the LV inhomogeneity index and Cx43 protein, the probability to induce ventricular tachyarrythmias was low in both genotypes following TAC procedure. Any differences in tachyarrythmia induction between the genotypes might be masked by the low susceptibility to tachyarrythmia induction in this model. The conduction velocity tended to be lower in Ampkα1
-/-mice than in Ampkα1 +/+ mice, but decreased significantly following TAC treatment only in Ampkα1 +/+ mice. The scatter of the data precludes safe conclusions but other mechanisms than Ampkα1-sensitive Cx43 regulation may contribute to modifications of conduction velocity. Ampk sensitivity of cardiac conduction velocity may be influenced by regulation of further ion channels, such as the voltage-gated Na + channels, which are activated by Ampk [11] . Furthermore, Cx43 may not be the major determinant of cardiac conduction velocity [49, 50] . Cx43 also exerts effects independent of gap junction function [51] . Nonetheless, reduction and lateralization of Cx43 protein causes conduction defects in the failing heart [52, 53] . Cx43 is reduced following pressure overload induced by TAC and congestive heart failure, but Cx43 is not decisive for cardiac contractile function [54] [55] [56] . The downregulation of connexins by Ampk presumably serves to protect neighbours of energy depleted cells from Na + and K + fluxes through gap junctions due to impaired Na + /K + -ATPase activity in energy depleted cells [57] . Cx43 internalization is an important mechanism during cardiac ischemia [58] . Cardiac ischemia activates Ampkα1 [59] , which exerts protective effects in the ischemic heart [60, 61] . Similarly, inhibition of Cx43 mitigates cardiac ischemia reperfusion injury [62] . Inhibition of Cx43 by Ampk could serve to protect the heart from ischemic episodes. Chronic pressure overload causes activation and increased activity of Ampk [8] . During chronic activation, such as in heart failure, the inhibitory actions of Ampk on Cx43 might lead to detrimental loss of gap junctions and impaired cardiac conductance.
Mutations in the gamma subunit of Ampk are associated with increased Ampk activity, ventricular preexcitation and conduction defects [63, 64] . The effects of the mutated Ampk are not solely due to increased glycogen storage [36] . Ampk activity is increased following pressure overload, increasing the expression of the Ampkα1 isoform, but rather reducing the Ampkα2 isoform [8] . Ampkα2 activation is protective in the failing heart [5] . Ampkα2-deficient mice, but not Ampkα1-deficient mice show dysfunctional expression of energy metabolism-related genes and exacerbated remodeling following TAC [65, 66] . Therefore, the effects of Ampkα1 could be of significant importance especially in the failing heart.
In conclusion, Ampkα1 negatively regulates Cx43 protein expression by increasing the ubiquitination-mediated degradation and thus impacts on gap junction coupling. These observations suggest that the previously observed isoform shift towards Ampkα1 in human heart failure and an increased Ampkα1 activity [9] may cause detrimental effects on gap junction remodeling.
